The TNM staging of LRCC is still the most important determinant of disease recurrence and death [19], and the tumor diameter is the standard for the TNM staging of LRCC. In 1987, the tumor diameter cutoff point for LRCC prognosis is first located at 2.5 cm [20]. In 1997, on the basis of the survival rate of RCC, epidemiological characteristics, and research observations, 2.5 cm is changed to 7 cm as the cutoff point to judge the prognosis of LRCC [21]. With the support of follow-up research and a large number of reviews and other evidence-based medicine, 4 cm is further determined as the optimal cutoff point for judging the prognosis of LRCC in T1, which is further divided into T1a and T1b. Based on these values, ≤ 4 cm is selected as the surgical selection criterion for partial nephrectomy [22–24]. In 2010, AJCC has revised the TNM staging of RCC. On the basis of the original determination, 10 cm is used as the cutoff point for the tumor diameter of T2a and T2b in stage T2. In the past 10 years, 7 cm is used as the cutoff point for the classification of stages T1 and T2, whereas 4 cm is used as the T1a and T1b cutoff point, and 10 cm is used as the T2a and T2b cutoff point, which is widely used clinically. However, with a large number of clinical observations, these optimal cutoff points for evaluating the prognosis of LRCC are questioned by various studies [1, 14, 15] and needed to be constantly revised on the basis of big data. For example, Hafez et al. [25] have analyzed a group of patients undergoing selective partial nephrectomy. The tumor-specific mortality of patients with RCC with 4 cm tumor diameter is higher than that of patients at stage T1b. Elmore et al. [26] have analyzed the survival and tumor recurrence of patients with RCC undergoing radical nephrectomy. The analysis has revealed that the difference between stages I and II cannot be stratified when the threshold value of stages I and II in TNM in 1997 is 7 cm. Patients with tumor measurement range between 5.1 and 7.0 cm have shown the same survival rate as patients with the disease at stage II. Therefore, 7 cm is evidently a high cutoff point. Similarly, Waalke et al. [15] have confirmed that the diameter cutoff point of 10 cm, as the standard of T2 subclassification, cannot independently predict tumor-specific mortality in patients with RCC. Many scholars have successively put forward proposals to modify the TMN staging criteria for RCC, and several cutoff points for tumor diameter are proposed to stratify the prognosis of LRCC on the basis of the analysis of the clinical data of large samples. A range of tumor diameter cutoff points from 4.5 cm to 5.5 cm is recommended in most studies [25–28]. The 2019 EAU guidelines on RCC [1] have clearly proposed that 4 cm is not the best choice as a cutoff value to subclassify T1 tumors, and the size stratification value of T2 tumors is also widely questioned. In 2011, Waalkes et al. [15] have analyzed 5122 patients with RCC undergoing surgery from three centers in Germany. In accordance with the 2010 AJC TNM classification, 579 patients are divided into stages T2a (445, 76.9%) and T2b (134, 23.1%). The Kaplan-Meier curve has shown no significant difference in CSS (cancer specific survive) between T2a and T2b patients, which have 5-year CSS of 79.0% and 74.1%, respectively (P = 0.38). Therefore, tumor diameter 10 cm, as cutoff point for the prognosis of RCC during stage II, should be revised as necessary.
In this research, the multifactor COX analysis is used to analyze the stratification effect of the 2010 AJCC TNM on the prognosis of LRCC. Results show that the tumor diameter at 7 cm (HR = 2.44, CI: 1.45–4.11; P = 0.00) can achieve the classification of the prognosis of patients with RCC at stages T1 and T2. However, 4 (HR = 1.76, CI: 0.87–3.56; P = 0.12) and 10 (HR = 1.58, CI: 0.69–3.62; P = 0.28) cm cannot achieve the classification of the expected prognosis for the subclassification of stages T1 and T2. Therefore, patients with RCC at stages T1 and T2 are separately analyzed to screen for the tumor cutoff points for the new tumor staging subclassification. Further analysis has confirmed that the cutoff point of T1 tumor diameter is 4.5 cm (HR = 2.00, CI: 1.04–3.87; P = 0.04) and the cutoff point of the T2 tumor is 11 cm (HR = 2.75, CI: 1.14–6.63; P = 0.02). Our research results and the existing literature reports share the common understanding on the 4 and 10 cm as the optimal cutoff points for T1 and T2 subclassification. These two cutoff points are somewhat controversial for the prognosis of LRCC [1, 15, 23]. However, the optimal cutoff point of the tumor diameter redetermined using different studies is somewhat different. Researchers believe that this finding is closely related to various factors, such as tumor heterogeneity, race, genes, diagnosis and treatment levels, and changes in survival environment and economic levels. Our research is targeted at the Chinese population and is an important supplement to the TNM of RCC.
Reasonable and effective classification suggestions are initiated for the long-term prognosis of patients with RCC at stages T1 and T2 in this research, which provide important reference data for the updating of the T staging system. Based on the results of this study, the indication for partial nephrectomy of LRCC patients can be increased from 4 cm to 4.5 cm. This increase can change the conservative clinical status when 4 cm is regarded as the gold standard for partial nephrectomy and avoid blindly expanding the indication of partial nephrectomy, thereby corresponding to the actual clinical requirements.
This study has certain limitations. First, the median follow-up is 49.8 months (3-103 months). A longer clinical follow-up observation is required for the results to be more convincing. Second, our conclusion is based on a retrospective analysis of the follow-up observations of patients with RCC undergoing surgery in a single center. Verification through the use of multiple centers or other large prospective studies is needed to support our conclusions and provide a theoretical basis for redefining the TNM stage of LRCC.